CASE REPORT
Differential diagnosis of a clinically isolated syndrome in a 17-year-old patient
Publication date: 2018-07-20
Pediatr Pol 2018;93(3):275-279
KEYWORDS
ABSTRACT
We present a case of a 17-year-old girl with sensory disturbances and numbness in the left upper limb, left lower limb, and the part of face and tongue. Brain magnetic resonance imaging revealed an irregular area with high-signal intensity on T2 sequence and FLAIR sequence placed in the lower part of the right thalamus, right cerebral peduncle, right substantia nigra, and lateral part of the red nucleus. Differential diagnosis included a demyelination process and inflammatory process caused by infectious factors and the autoimmune process. The pathologic area decreased after high-dose methylprednisolone therapy. Ultimately, we made a diagnosis of clinically isolated syndrome.
REFERENCES (14)
1.
Miller DH, Weinshenker BG, Filippi M i wsp. Diagnostyka różnicowa w przypadkach podejrzenia stwardnienia rozsianego: konsensus. Neurol Prakt 2011; 6: 15-27.
2.
Swanton JK, Rovira A, Tintore M i wsp. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007; 6: 677-686.
3.
Tumani H, Sapunova-Mayer I, Süssmuth SD i wsp. CIS case studies. J Neurol Sci 2009; 287 Suppl 1: S7-10.
4.
4Banwell B, Bar-Or A, Arnold DL i wsp. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011; 10: 436-445.
5.
Miller DH, Weinshenker BG, Filippi M i wsp. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008; 14: 1157-1174.
6.
Filippi M, Rocca MA, Ciccarelli O i wsp.; on behalf of the MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016; 15: 292-303.
8.
Hummel HM, Bruck W, Dreha-Kulaczewski S i wsp. Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI. Mult Scler 2013; 19: 1330-1335.
9.
Brettschneider J, Czerwoniak A, Senel M i wsp. The chemokine CXCL13 a prognostic marker in clinically isolated syndrom (CIS). PLoS One 2010; 5: e11986.
10.
Walecki J. Neuroradiologia. Wydawnictwo Naukowe Upowszechnienie Nauki – Oświata – “UN-O”, Warszawa 2000.
11.
Michałowska-Wener G, Wender M. Peripheral blood cell immunomarkers in the course of methylprednisolone treatment of multisclerosis relapses. Folia Neuropathol 2008; 46: 134-138.
12.
Michałowska-Wender G, Losy J, Biernacka-Łukanty J, Wender M. Impact of methylprednisolone treatment on the expression of macrophage inflammatory protein 3α and B lymphocyte chemoattractant in serum of multiple sclerosis patients. Pharmacol Rep 2008; 60: 549-554.
14.
Polman CH, Reingold SC, Banwell B i wsp. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
